nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—Cloperastine—Raloxifene—breast cancer	0.894	1	CrCrCtD
Procyclidine—Biperiden—CYP2D6—breast cancer	0.000671	0.316	CrCbGaD
Procyclidine—Oxybutynin—CYP2D6—breast cancer	0.000523	0.246	CrCbGaD
Procyclidine—Biperiden—ABCB1—breast cancer	0.000479	0.226	CrCbGaD
Procyclidine—Oxybutynin—CYP3A4—breast cancer	0.000448	0.211	CrCbGaD
Procyclidine—CHRM2—Signaling Pathways—NRG1—breast cancer	1.74e-05	0.000167	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3CD—breast cancer	1.73e-05	0.000167	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—E2F1—breast cancer	1.73e-05	0.000167	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—E2F1—breast cancer	1.73e-05	0.000166	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	1.73e-05	0.000166	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—H2AFX—breast cancer	1.72e-05	0.000166	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—IL2—breast cancer	1.72e-05	0.000166	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	1.72e-05	0.000165	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—PIK3CA—breast cancer	1.72e-05	0.000165	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SERPINE1—breast cancer	1.72e-05	0.000165	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—E2F1—breast cancer	1.71e-05	0.000165	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	1.7e-05	0.000164	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—KRAS—breast cancer	1.7e-05	0.000163	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SPP1—breast cancer	1.67e-05	0.00016	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SPP1—breast cancer	1.66e-05	0.00016	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CXCL8—breast cancer	1.66e-05	0.00016	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CXCL8—breast cancer	1.65e-05	0.000159	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ERBB3—breast cancer	1.65e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGFR2—breast cancer	1.64e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SPP1—breast cancer	1.64e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ERBB3—breast cancer	1.64e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGFR2—breast cancer	1.64e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NOS3—breast cancer	1.64e-05	0.000158	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	1.64e-05	0.000157	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ERBB3—breast cancer	1.63e-05	0.000156	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGFR2—breast cancer	1.62e-05	0.000156	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CG—breast cancer	1.59e-05	0.000153	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL2—breast cancer	1.58e-05	0.000152	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL2—breast cancer	1.58e-05	0.000152	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TERT—breast cancer	1.58e-05	0.000152	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TERT—breast cancer	1.57e-05	0.000151	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL2—breast cancer	1.56e-05	0.00015	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—PIK3CA—breast cancer	1.56e-05	0.00015	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TERT—breast cancer	1.56e-05	0.00015	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MDM2—breast cancer	1.55e-05	0.000149	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RAF1—breast cancer	1.55e-05	0.000149	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RELA—breast cancer	1.54e-05	0.000148	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGFR1—breast cancer	1.53e-05	0.000147	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ERBB2—breast cancer	1.53e-05	0.000147	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGFR1—breast cancer	1.53e-05	0.000147	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGFR1—breast cancer	1.51e-05	0.000146	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3CB—breast cancer	1.51e-05	0.000145	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MTOR—breast cancer	1.51e-05	0.000145	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HIF1A—breast cancer	1.51e-05	0.000145	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HIF1A—breast cancer	1.51e-05	0.000145	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HIF1A—breast cancer	1.49e-05	0.000143	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LEP—breast cancer	1.47e-05	0.000142	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LEP—breast cancer	1.47e-05	0.000141	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CAV1—breast cancer	1.46e-05	0.00014	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CAV1—breast cancer	1.46e-05	0.00014	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LEP—breast cancer	1.45e-05	0.00014	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CXCL8—breast cancer	1.45e-05	0.00014	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—KDR—breast cancer	1.44e-05	0.000139	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HRAS—breast cancer	1.44e-05	0.000139	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CAV1—breast cancer	1.44e-05	0.000139	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—KDR—breast cancer	1.44e-05	0.000138	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—KDR—breast cancer	1.43e-05	0.000137	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CDKN1B—breast cancer	1.42e-05	0.000136	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ESR1—breast cancer	1.41e-05	0.000135	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—AKT1—breast cancer	1.4e-05	0.000135	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ESR1—breast cancer	1.4e-05	0.000135	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CD—breast cancer	1.39e-05	0.000134	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CASP3—breast cancer	1.39e-05	0.000134	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FN1—breast cancer	1.39e-05	0.000134	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ESR1—breast cancer	1.39e-05	0.000134	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL2—breast cancer	1.39e-05	0.000134	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FN1—breast cancer	1.39e-05	0.000133	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL6—breast cancer	1.38e-05	0.000133	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ALB—breast cancer	1.38e-05	0.000132	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NFKBIA—breast cancer	1.37e-05	0.000132	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FN1—breast cancer	1.37e-05	0.000132	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NFKBIA—breast cancer	1.37e-05	0.000132	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOTCH1—breast cancer	1.36e-05	0.000131	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOTCH1—breast cancer	1.36e-05	0.00013	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	1.36e-05	0.00013	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCND1—breast cancer	1.35e-05	0.00013	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—JUN—breast cancer	1.35e-05	0.00013	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	1.34e-05	0.000129	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CTNNB1—breast cancer	1.34e-05	0.000129	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—KIT—breast cancer	1.33e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—APC—breast cancer	1.33e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	1.33e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—KIT—breast cancer	1.33e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—APC—breast cancer	1.33e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CG—breast cancer	1.33e-05	0.000128	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—NOS3—breast cancer	1.32e-05	0.000127	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EGF—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MMP9—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—APC—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—KIT—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EGF—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CDKN1A—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PTEN—breast cancer	1.31e-05	0.000126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EGF—breast cancer	1.3e-05	0.000125	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MAPK8—breast cancer	1.28e-05	0.000123	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—AKT1—breast cancer	1.27e-05	0.000123	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	1.27e-05	0.000123	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—MAPK3—breast cancer	1.27e-05	0.000122	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	1.26e-05	0.000121	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—BRAF—breast cancer	1.25e-05	0.00012	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—BRAF—breast cancer	1.25e-05	0.00012	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—BRAF—breast cancer	1.23e-05	0.000119	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF1—breast cancer	1.22e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT2—breast cancer	1.22e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CB—breast cancer	1.22e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF1—breast cancer	1.21e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT2—breast cancer	1.21e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—EGFR—breast cancer	1.21e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SRC—breast cancer	1.21e-05	0.000117	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—EGFR—breast cancer	1.21e-05	0.000116	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTGS2—breast cancer	1.2e-05	0.000116	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF1—breast cancer	1.2e-05	0.000116	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT2—breast cancer	1.2e-05	0.000116	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—EGFR—breast cancer	1.2e-05	0.000115	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—VEGFA—breast cancer	1.18e-05	0.000114	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	1.17e-05	0.000112	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—STAT3—breast cancer	1.17e-05	0.000112	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CD—breast cancer	1.17e-05	0.000112	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	1.16e-05	0.000111	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	1.16e-05	0.000111	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	1.15e-05	0.000111	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	1.15e-05	0.000111	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SERPINE1—breast cancer	1.15e-05	0.000111	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—KRAS—breast cancer	1.14e-05	0.00011	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	1.14e-05	0.00011	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	1.14e-05	0.00011	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—KRAS—breast cancer	1.14e-05	0.00011	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—KRAS—breast cancer	1.13e-05	0.000109	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MAPK3—breast cancer	1.12e-05	0.000107	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOS3—breast cancer	1.1e-05	0.000106	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOS3—breast cancer	1.1e-05	0.000106	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOS3—breast cancer	1.09e-05	0.000105	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MYC—breast cancer	1.09e-05	0.000104	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TGFB1—breast cancer	1.08e-05	0.000104	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EGFR—breast cancer	1.06e-05	0.000102	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	1.05e-05	0.000101	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTEN—breast cancer	1.05e-05	0.000101	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	1.05e-05	0.000101	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MDM2—breast cancer	1.05e-05	0.000101	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MDM2—breast cancer	1.04e-05	0.0001	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RAF1—breast cancer	1.04e-05	0.0001	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RAF1—breast cancer	1.04e-05	0.0001	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RELA—breast cancer	1.04e-05	0.0001	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	1.04e-05	9.99e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RELA—breast cancer	1.04e-05	9.97e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MDM2—breast cancer	1.03e-05	9.95e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ERBB2—breast cancer	1.03e-05	9.94e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RAF1—breast cancer	1.03e-05	9.91e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ERBB2—breast cancer	1.03e-05	9.9e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RELA—breast cancer	1.03e-05	9.87e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ERBB2—breast cancer	1.02e-05	9.81e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MTOR—breast cancer	1.02e-05	9.81e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	1.02e-05	9.81e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MTOR—breast cancer	1.02e-05	9.77e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CB—breast cancer	1.02e-05	9.77e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	1.01e-05	9.68e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MTOR—breast cancer	1.01e-05	9.68e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—KRAS—breast cancer	1e-05	9.65e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CXCL8—breast cancer	9.79e-06	9.42e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CXCL8—breast cancer	9.76e-06	9.39e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HRAS—breast cancer	9.73e-06	9.36e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HRAS—breast cancer	9.7e-06	9.33e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CXCL8—breast cancer	9.67e-06	9.3e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HRAS—breast cancer	9.61e-06	9.24e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	9.57e-06	9.2e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDKN1B—breast cancer	9.54e-06	9.17e-05	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	9.46e-06	9.1e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	9.44e-06	9.08e-05	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—AKT1—breast cancer	9.43e-06	9.07e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CASP3—breast cancer	9.37e-06	9.02e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL2—breast cancer	9.36e-06	9.01e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CASP3—breast cancer	9.35e-06	8.99e-05	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	9.34e-06	8.99e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL2—breast cancer	9.33e-06	8.98e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL6—breast cancer	9.31e-06	8.96e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL6—breast cancer	9.28e-06	8.93e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CASP3—breast cancer	9.25e-06	8.9e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL2—breast cancer	9.24e-06	8.89e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3CA—breast cancer	9.22e-06	8.87e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL6—breast cancer	9.19e-06	8.85e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCND1—breast cancer	9.13e-06	8.78e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—JUN—breast cancer	9.11e-06	8.76e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCND1—breast cancer	9.1e-06	8.75e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—JUN—breast cancer	9.08e-06	8.73e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	9.04e-06	8.69e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCND1—breast cancer	9.01e-06	8.67e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	9.01e-06	8.67e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—JUN—breast cancer	8.99e-06	8.65e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	8.92e-06	8.58e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TP53—breast cancer	8.91e-06	8.58e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MMP9—breast cancer	8.86e-06	8.52e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MMP9—breast cancer	8.83e-06	8.5e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	8.83e-06	8.49e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTEN—breast cancer	8.81e-06	8.47e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	8.8e-06	8.47e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTEN—breast cancer	8.78e-06	8.45e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MMP9—breast cancer	8.75e-06	8.41e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	8.71e-06	8.38e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTEN—breast cancer	8.69e-06	8.36e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAPK8—breast cancer	8.62e-06	8.29e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AKT1—breast cancer	8.59e-06	8.27e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAPK8—breast cancer	8.59e-06	8.26e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AKT1—breast cancer	8.57e-06	8.24e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HRAS—breast cancer	8.53e-06	8.2e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAPK8—breast cancer	8.51e-06	8.18e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AKT1—breast cancer	8.48e-06	8.16e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SRC—breast cancer	8.17e-06	7.86e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL6—breast cancer	8.16e-06	7.85e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SRC—breast cancer	8.14e-06	7.83e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SRC—breast cancer	8.06e-06	7.76e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—VEGFA—breast cancer	7.96e-06	7.65e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—VEGFA—breast cancer	7.93e-06	7.63e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—STAT3—breast cancer	7.88e-06	7.58e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—VEGFA—breast cancer	7.85e-06	7.55e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—STAT3—breast cancer	7.85e-06	7.55e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—STAT3—breast cancer	7.78e-06	7.48e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT1—breast cancer	7.53e-06	7.24e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAPK3—breast cancer	7.53e-06	7.24e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAPK3—breast cancer	7.5e-06	7.22e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAPK3—breast cancer	7.43e-06	7.15e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CA—breast cancer	7.41e-06	7.13e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MYC—breast cancer	7.32e-06	7.04e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TGFB1—breast cancer	7.3e-06	7.02e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MYC—breast cancer	7.3e-06	7.02e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TGFB1—breast cancer	7.28e-06	7e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MYC—breast cancer	7.23e-06	6.95e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TGFB1—breast cancer	7.21e-06	6.93e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EGFR—breast cancer	7.16e-06	6.89e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EGFR—breast cancer	7.14e-06	6.87e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EGFR—breast cancer	7.07e-06	6.8e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—KRAS—breast cancer	6.76e-06	6.51e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—KRAS—breast cancer	6.74e-06	6.49e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—KRAS—breast cancer	6.68e-06	6.42e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	6.21e-06	5.98e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	6.19e-06	5.96e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	6.13e-06	5.9e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AKT1—breast cancer	6.05e-06	5.82e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TP53—breast cancer	6.01e-06	5.78e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TP53—breast cancer	5.99e-06	5.76e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TP53—breast cancer	5.93e-06	5.71e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HRAS—breast cancer	5.75e-06	5.53e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HRAS—breast cancer	5.73e-06	5.51e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HRAS—breast cancer	5.67e-06	5.46e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6—breast cancer	5.5e-06	5.29e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6—breast cancer	5.48e-06	5.28e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6—breast cancer	5.43e-06	5.23e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT1—breast cancer	5.08e-06	4.88e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT1—breast cancer	5.06e-06	4.87e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT1—breast cancer	5.01e-06	4.82e-05	CbGpPWpGaD
